Yuekang Pharmaceutical (688658.SH) subsidiary's YKYY036 injection receives NMPA and FDA clinical trial approval.

Zhitong Finance APP News, Youcare Pharmaceutical (688658.SH) announced that its subsidiaries Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. and Youcare Pharmaceutical Group Hangzhou Tianlong Pharmaceutical Co., Ltd. recently received the "Drug Clinical Trial Approval Notice" approved and issued by the National Medical Products Administration (NMPA) for YKYY036 injection for obesity or overweight. At the same time, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. recently received a letter from the U.S. Food and Drug Administration (FDA) approving the clinical trial application for YKYY036 injection for overweight or obesity (Study May Proceed Letter, IND number: 183361).